How We Got Here: Baxalta And Shire Reach Final Merger Hurdle

Following Baxalta Inc.'s announcement that it will hold a special meeting of stockholders on May 27 for investors to cast the final vote on its merger agreement with specialty biopharma company Shire, Scrip has taken a look back over the last year to see how this $32bn deal got made.